semaglutide soul SOUL: Oral Cuts CV Events in Diabetic Patients Oral Semaglutide Gets FDA Approval

Join the conversation to better understand what GLP-1 momentum could mean for the future of the food and beverage category

In March, the pharmaceutical company behind the blockbuster diabetes-turned-weight loss drug Ozempic held its Capital Markets Day presentations and held a breakout session devoted to its strong showing and trajectory in China

Patients considering Ozempic for weight loss should be aware of the drugs administration schedule, potential side effects, insurance coverage, and its effectiveness as supported by clinical trials

As a former general manager and owners IV hydration company, I will 100% support this company on their staff